CoChat

Chemoprevention of Prostate Cancer

Walsh, Patrick C. · 2010 · New England Journal of Medicine
Cited by 86

The DOI matches its Crossref record.

Abstract

Are we making progress in the chemoprevention of prostate cancer? The disease is an ideal target: not only is it the most common cancer among men in the United States, it has the highest age-specific incidence of any cancer. If we could prevent the disease or delay its progression, many men could be spared the burden of diagnostic procedures and treatments, and costs to the health care system could be reduced substantially. Because we lack a complete understanding of the pathophysiology of prostate cancer, chemopreventive strategies have empirically focused on two approaches: treatment with antioxidants to reduce damage to DNA . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejme1001045

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 86

Metadata

Authors
Walsh, P. C.
Venue
New England Journal of Medicine
Published
2010-04
Volume
362
Issue
13
Pages
1237-1238
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2014754399
Cited by
86
References
0
FWCI
15.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemoprevention of Prostate Cancer. https://app.cochat.ai/papers/10.1056/nejme1001045
The paper
Walsh, P. C. (2010). Chemoprevention of Prostate Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejme1001045

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.